Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

IntelGenx Technologies Corp. (IGXT) Represents a New Generation of Oral Drug Delivery Technologies

Montreal-based IntelGenx (OTCQX: IGXT), a leading oral drug delivery technology company, uses a suite of proprietary technologies to provide its pharmaceutical partners with a range of superior and cutting-edge drug delivery solutions. The company’s underlying mission is to be the primary medical choice when it comes to oral solid dose innovation. IntelGenx proprietary technologies include […]

eXp World Holdings, Inc. (EXPI) Adds Russ Cofano to Management Team

Earlier today, eXp World Holdings, Inc. (OTCQB: EXPI) announced the addition of industry veteran Russ Cofano to its management team. Cofano will serve as EXPI’s chief strategy officer and general counsel moving forward. “I have been looking for ‘the next great opportunity’ within the industry, and I’m certain that I’ve found that opportunity at eXp,” […]

Momentous Entertainment Group, Inc. (MMEG) Video Content Streaming Deal with Poolworks Germany Social Network is an Industry Template

The deal with 10 million-plus subscriber Poolworks Germany is a perfect fit for an acquisitive and already diversified entertainment and direct response marketing company like Momentous Entertainment Group, Inc. (OTC: MMEG). Momentous has an operational footprint spanning unique content production for documentary, film and reality TV, as well as live music events, adult contemporary and […]

International Stem Cell Corp. (ISCO) Announces Successful Intracranial Cell Transplantation in Phase I Clinical Study of ISC-hpNSC

Before the opening bell, International Stem Cell Corp. (OTCQB: ISCO) announced that the first patient in its ongoing phase I clinical trial of human parthenogenetic neural stem cells (ISC-hpNSC) for the treatment of moderate to severe Parkinson’s disease has undergone a successful intracranial transplant of ISC-hpNSC at the Royal Melbourne Hospital in Australia. This milestone […]

Content Checked (CNCK) CEO Authors Piece for Home Business® ONLINE

Kris Finstad, CEO of Content Checked Holdings, Inc. (OTCQB: CNCK), recently penned an article for Home Business® ONLINE, the web-based counterpart of the largest magazine targeting the home-based business sector with an audience of roughly 54,000 unique monthly visitors. In the piece, titled ‘How to Turn a Passion Project into a Viable Business’, Finstad details […]

 

From Our Blog

Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) at the Crossroads of National Security and Critical Mineral Supply

September 15, 2025

The intersection of national security and mineral supply chains has reached a turning point. China’s export restrictions to the U.S. on critical minerals like gallium, germanium, antimony, and graphite, combined with its dominance in mineral processing, has transformed resource development in the U.S. from an economic issue into a strategic necessity. When congressional delegations make […]

Rotate your device 90° to view site.